Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Applied Genetic Technologies Corporation (AGTC)

0.7801   0.01 (1.31%) 07-02 18:57
Open: 0.78 Pre. Close: 0.77
High: 0.79 Low: 0.77
Volume: 139,009 Market Cap: 40(M)
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing an optogenetic product candidate to treat advanced retinal disease. In addition, the company has initiated one preclinical program in otology; and two preclinical programs in targeting central nervous system disorders, including frontotemporal dementia and amyotrophic lateral sclerosis. It has collaboration agreements with University of Florida; Bionic Sight, LLC; and Otonomy, Inc. Applied Genetic Technologies Corporation was incorporated in 1999 and is headquartered in Alachua, Florida.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.78 - 0.79 0.79 - 0.79
Low: 0.72 - 0.73 0.73 - 0.73
Close: 0.76 - 0.77 0.77 - 0.77

Technical analysis

as of: 2022-07-01 4:19:54 PM
Overall:       
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 1.11     One year: 1.3
Support: Support1: 0.72    Support2: 0.57
Resistance: Resistance1: 0.95    Resistance2: 1.11
Pivot: 0.77
Moving Average: MA(5): 0.75     MA(20): 0.81
MA(100): 1.19     MA(250): 2.12
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 53     %D(3): 48.8
RSI: RSI(14): 46.1
52-week: High: 4.13  Low: 0.57
Average Vol(K): 3-Month: 409 (K)  10-Days: 355 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ AGTC ] has closed below upper band by 49.8%. Bollinger Bands are 59.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 29 Jun 2022
Applied Genetic Technologies Co. (NASDAQ:AGTC) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Fri, 17 Jun 2022
AGTC: Exporters express frustration with ocean carriers - American Journal of Transportation

Tue, 14 Jun 2022
AGTC hails imminent passage of Ocean Shipping Reform Act - American Journal of Transportation

Wed, 08 Jun 2022
AGTC Announces Key Appointments to Leadership Team - GlobeNewswire

Tue, 07 Jun 2022
AgTC shares trade priorities ahead of 2022 meeting - Meatingplace.com

Mon, 06 Jun 2022
AGTC to Present Three-Month Interim Results from the SKYLINE Clinical Trial of AGTC-501 for the Treatment of X-Linked Retinitis Pigmentosa at the 45th Macula Society Annual Meeting - GlobeNewswire

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 51 (M)
% Held by Insiders 5.043e+007 (%)
% Held by Institutions 1.2 (%)
Shares Short 1,770 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -6.077e+007
EPS Est Next Qtl 0.02
EPS Est This Year -0.82
EPS Est Next Year -1.64
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -12
Return on Assets (ttm) 447.3
Return on Equity (ttm) -35.9
Qtrly Rev. Growth 500000
Gross Profit (p.s.) 0
Sales Per Share -52.77
EBITDA (p.s.) -1.36848e+007
Qtrly Earnings Growth -1.5
Operating Cash Flow 0 (M)
Levered Free Cash Flow -61 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.02
Price to Cash Flow 1.38

Stock Dividends

Dividend 0
Forward Dividend 1.53e+006
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.